MedicX Fund (LSE: MXF) announces that, pursuant to its scrip dividend scheme (the "Scrip Dividend Alternative"), 238,099 ordinary shares of no par value in the Company ("Shares") will be sold out of treasury by the Company on 29 June 2012 to shareholders who elected to participate in the Scrip Dividend Alternative.† Electing shareholders will receive the Shares in lieu of receiving cash for the June 2012 interim dividend in respect of the quarter ended 31 March 2012.
Elections pursuant to the Scrip Dividend Alternative were received in respect of 5.3 per cent. of the ordinary shares in issue as at the record date of 18 May 2012. †The Shares will rank pari passu with the existing ordinary shares.
Following the transaction, the Company will have 263,645,780 ordinary shares in issue, of which 6,779,564 will be held in treasury.† Accordingly the total voting rights in issue will be 256,866,216.
Copies of the documents relating to the Scrip Dividend Alternative are available for inspection through the National Storage Mechanism (http://www.hemscott.com/nsm.do).
MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 73 properties.
The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 28 people operating across the†UK. †
The Company's website address is†www.medicxfund.com.† Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website),nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.†
This information is provided by RNS
The company news service from the London Stock Exchange
Datafeed and UK data supplied by NETbuilder and Interactive Data.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.